Panel Says US Drug Safety System Needs Major Reforms Sep 23, 2006
...report said that this lack was acutely visible in the way the agency handled safety issues associated with the cholesterol-lowering drug Baycol, the painkiller ... -Food Consumer
Don't license drugs for life Sep 16, 2006
And yet our confidence has been shaken in recent years by revelations about risks emerging in such drugs as Vioxx, Ketek, Baycol and all the antidepressants. ... -Dallas Morning News (subscription)
Bayer Profit Rises 11%, Led by Nexavar and Kogenate (Update4) Aug 29, 2006
The division had suffered from the recall of the cholesterol- lowering Baycol medicine in August 2001 and the introduction of generic rivals to its Cipro ... -Bloomberg
American farmers sue Bayer over GM rice Aug 29, 2006
The lawsuit is the latest litigation to hit Bayer, which is still reeling from the 2001 recall of its Baycol cholesterol-lowering medication. ... -Times Online
UCSD Study Finds Troubling Statin Cholesterol Drugs Side Effects Sep 16, 2006
...and Lescol. Another statin drug, Baycol, was recalled several years ago after high rates of rhabdomyolysis were reported. Statins ... -Newsinferno.com
Letters for Tuesday Sep 19, 2006
The problems with the pharmaceuticals mentioned – Vioxx, Ketek, Baycol – was not with the specific medications but in which circumstances they were used. ... -Dallas Morning News (subscription)
AFX NEWS BRIEFING: Pharmaceuticals and chemicals highlights to 15 ... Aug 29, 2006
LEVERKUSEN, Germany (AFX) - Bayer AG said the number of cases pending against it regarding the anti-cholesterol drug Lipobay/Baycol was 3,000 as of Aug 18. ... -Hemscott
Bayer profit rose 11%; will cut 1,500 at CropScience Aug 29, 2006
It didn't take any charges in the second quarter on sales of Lipobay, also known as Baycol, a cholesterol drug that triggered a fatal muscle reaction. ... -MarketWatch
Marchin' for Merck in New Orleans Aug 6, 2006
...election. He also scored a victory on behalf of Bayer AG in 2003 in the first trial over its controversial Baycol cholesterol drug. ... -Chicago Tribune
Hormone Replacement Therapy Drugs Mixed by Pharmacies Are Unsafe ... Aug 2, 2006
For example, Public Citizen warned consumers about the dangers of Vioxx, ephedra, Baycol and Propulsid and why people should not use these drugs years before ... -Common Dreams
Milberg Weiss files fewer cases after indictment Aug 4, 2006
A federal judge in Manhattan last month replaced it as lead counsel in a case against Bayer AG involving cholesterol drug Baycol after the named plaintiff, the ... -Business Insurance
Insurance finalists Jul 20, 2006
...in the approval of a class settlement valued at $1 billion; appointed by the Los Angeles Superior Court Judge overseeing the Baycol (Cholesterol lowering drug ... -San Diego Daily Transcript (subscription)
AstraZeneca Deal Is Response To Mkt Pressure Jul 6, 2006
However, notes the combination of statins with fibrates has shown negative side effects in the past, such as in the case of Bayer's (BAY) Baycol. ... -newratings.com
Lawyers gear up to attack Fosamax Jul 10, 2006
Litigation involving silicone gel breast implants and Bayer's cholesterol-lowering drug Baycol proved less successful than lawyers initially expected, said ... -Chicago Tribune
FDA's Monitoring of Post-approval Studies Inadequate - Report Jul 10, 2006
...report said that this lack was acutely visible in the way the agency handled safety issues associated with the cholesterol-lowering drug Baycol, the painkiller ... -Food Consumer
Bayer starts €1.2 bln share sale for Schering Jul 7, 2006
Bayer HealthCare suffered from the recall of the cholesterol-lowering Baycol in August 2001 and the introduction of generic rivals to its Cipro antibiotic two ... -Budapest Business Journal
Bayer: More outlay for Schering justified Jun 21, 2006
Since it recalled its anti-cholesterol treatment Baycol in 2001 because of safety issues, Bayer has tried to find a partner for the unit. ... -BusinessWeek
FDA Failing to Protect Americans, Consumer Groups Charge Jun 27, 2006
...should not have been approved (including Crestor, Rezulin, and others), or should have been restricted (Accutane and others) or withdrawn (Baycol, Seldane, and ... -Consumer Affairs
Baycol Settlement Gets Preliminary Approval Apr 28, 2006
...with the nationwide class of all third-party payors that had to refund beneficiaries or insureds for purchases of the cholesterol reducer Baycol, a drug the ... - Therapeutics Daily (subscription)
Success of heart drugs masks cause of disease May 9, 2006
One high dose statin, called Baycol, was taken off the market because of the numbers of people developing a serious condition involving muscle breakdown. ... - Guardian Unlimited
GAO Issues Drug Report, Senator Sponsors Bill May 10, 2006
...and ineffective processes, which the GAO says it observed after examining four case studies of drugs with known safety issues: Arava, Baycol, Bextra and ... - RFID Journal
Nasal spray dependence is a hard habit to break May 10, 2006
I have been taking statin drugs to lower my cholesterol for many years. At first I took Baycol until it was pulled off the market. ... - Daily Press
FDA's drug safety process needs more work - GAO report Apr 24, 2006
GAO conducted an organizational review and case studies of four drugs with safety issues: Arava, Baycol, Bextra, and Propulsid. ... - Food Consumer
PEOPLE'S PHARMACY Can the FDA get its bite back? May 7, 2006
...concerns about the Vioxx debacle, the GAO looked at the agency's handling of four drugs with safety issues — Arava for rheumatoid arthritis, Baycol for high ... - Houston Chronicle
Law Offices of Peter G. Angelos Investigate Claims for Bausch & ... May 5, 2006
...attorneys at the Law Offices of Peter G. Angelos have represented victims of dangerous products like Guidant heart defibrillators, Vioxx, Baycol, Pondimin and ... - Emediawire
FDA slow to take up drug safety issues May 1, 2006
GAO’s examiners studied the agency’s handling of four controversial drugs — the cholesterol-lowering drug Baycol, the painkiller Bextra, the rheumatoid ... - Canton Repository (subscription)
A method for weaning yourself off nasal spray May 2, 2006
I have been taking statin drugs to lower my cholesterol for many years. At first I took Baycol until it was pulled off the market. I have taken Zocor since. ... - Charlotte Observer
Report: FDA needs more power Apr 24, 2006
It also examined case studies of four drugs -- the Sanofi-Aventis arthritis drug Arava, Bayer AG's withdrawn cholesterol pill Baycol, Pfizer Inc.'s recalled ... - CNN
Schering Advises Investors to Accept Bayer's Offer (Update1) Apr 18, 2006
Officer Werner Wenning is trying to rebuild the company's drug division after sales slumped following the recall of the cholesterol-lowering Baycol in August ... - Bloomberg
Bayer 1st-Quarter Net Falls 7.9% on Crop Chemicals (Update1) Apr 26, 2006
Bayer's health-care unit suffered from the recall of the cholesterol-lowering Baycol in August 2001 and the introduction of generic forms of its Cipro ... - Bloomberg
Bayer profits surprise; plastics, health robust Apr 27, 2006
Bayer's drugs unit has for long been seen as lacking depth in its pipeline, and was blighted by the $1 billion recall of cholesterol drug Baycol in 2001. ... - Reuters
Report faults FDA drug-safety unit Apr 25, 2006
...review of agency actions on four drugs approved by the FDA that were later pulled from the market for safety concerns: Arava, an arthritis drug; Baycol, a high ... - Boston Globe
Bayer, Merck and Altana See Surge in First-Quarter Drug Profit Apr 27, 2006
The companies are investing in cancer research after safety concerns forced Bayer to withdraw its Baycol anti-cholesterol medicine in 2001 and Merck faced ... - Bloomberg
FDA needs more power for postmarket drug safety, GAO says Apr 25, 2006
...report said that this lack was acutely visible in the way the agency handled safety issues associated with the cholesterol-lowering drug Baycol, the painkiller ... - Food Consumer
Scientists uncover gene mutation key to cholesterol control Apr 20, 2006
Drugs in this group include: Lipitor (atorvastatin); Baycol (cerivastatin); Lescol (fluvastatin); Mevacor (lovastatin); Pravachol (pravastatin); Zocor ... - DrugResearcher.com
FDA Does Not Have Effective Process For Monitoring Post-Market ... Apr 26, 2006
Joe Barton (R-Texas), researchers examined the agency's handling of four controversial drugs -- statin Baycol, painkiller Bextra, rheumatoid arthritis ... - Medical News Today
Study finds FDA too slow responding to Rx problems Apr 24, 2006
The GAO examiners studied the agency’s handling of four drugs — the cholesterol-lower- ing drug Baycol, the painkiller Bextra, the rheumatoid arthritis ... - Arkansas Democrat-Gazette (subscription)
Public Citizen Petitions FDA to Ban Xenical (orlistat) 10 Apr 2006
For example, Public Citizen warned consumers about the dangers of Vioxx, ephedra, Bextra, Rezulin, Baycol, Propulsid and many other drugs years before the ... - PharmaLive.com
Philadelphia court OKs Baycol settlement Mar 17, 2006
...settlement to reimburse health and welfare funds, self-insured employers and insurers' losses caused by the withdrawal of cholesterol medicine Baycol in August ... - BusinessWeek
Bayer class action settlement approved for Baycol Mar 17, 2006
...a state judge approved a class action settlement that would reimburse unions, employers and health plans for money spent on the recalled cholesterol drug Baycol ... - ABC News
In Baycol Class Action, Philadelphia Court Grants Preliminary ... Mar 17, 2006
...union health and welfare funds, self-insured employers, and insurers ("third-party payors"), for losses caused by the withdrawal of Baycol(R) cholesterol ... - PR Newswire
Bayer on the verge of Schering buyout Mar 26, 2006
The deal gives Bayer still smarting from a $1 billion recall of cholesterol drug Baycol in 2001 access to Schering's Yasmin, the world's top-selling oral birth ... - Irish Examiner
Key players in NJ Vioxx trial Apr 6, 2006
Philadelphia, has won $392 million in jury verdicts during his career in private practice and worked on silicone breast implant, Rezulin and Baycol litigation. ... - Cherry Hill Courier Post
Bayer Offers to Buy for Schering for EU16.3 Bln, Topping Merck Mar 23, 2006
Officer Werner Wenning is trying to rebuild the company's drug division after sales slumped following the recall of the cholesterol-lowering Baycol in August ... - Bloomberg
Schering accepts surprise Bayer bid Mar 24, 2006
For Bayer, which has struggled in drugs since the recall of its anti-cholesterol treatment, Baycol, due to safety concerns in 2001, and which failed a few ... - Sydney Morning Herald
Bayer set to win Schering as Merck pulls out Mar 24, 2006
The deal gives Bayer -- still smarting from a $1 billion (574 million pounds) recall of cholesterol drug Baycol in 2001 -- access to Schering's Yasmin, the ... - Reuters.uk
Bayer set to launch offer for rival drug maker Schering: report Mar 23, 2006
Bayer was plunged into a financial crisis when it was forced to withdraw its disgraced anti-cholesterol treatment Lipobay/Baycol from the market in 2001. ... - Middle East North Africa Financial Network
Schering’s board accepts €16.3bn cash bid from Bayer Mar 24, 2006
...shareholders. Bayer’s sales have been under pressure since the recall of its anti-cholesterol drug, Baycol, in August 2001. The ... - newratings.com
Bayer's offer for Schering embraced by investors Mar 24, 2006
Since it recalled the anti-cholesterol treatment Baycol in 2001 because of safety issues, Bayer has tried to find a partner for its drug unit. - WIS
Bayer Announces 20 Billion Dollar Offer For Rival Company Schering Mar 23, 2006
For Bayer, which has struggled in drugs since the recall of its anticholesterol treatment Baycol over safety concerns in 2001, and which tried fruitlessly a ... - The MIT Tech
Bayer's filings with SEC reveal two subpoenas Mar 7, 2006
...the company was subpoenaed by the US attorney in New Jersey in connection with an earlier federal subpoena over its withdrawn cholesterol drug, Baycol. ... - Pittsburgh Post Gazette
Bayer Bids 16.3 Bln Euros for Schering, Topping Merck, WSJ Says Mar 23, 2006
...after World War II. Bayer's drug division is still dealing with the recall of the cholesterol-lowering Baycol in August 2001. Bayer ... - Bloomberg
Bayer's Wenning Tries to Fix Drug Unit With Schering Purchase Mar 23, 2006
KGaA. Wenning, 59, took charge of Leverkusen, Germany-based Bayer in 2002 after the withdrawal of anti-cholesterol drug Baycol. ... - Bloomberg
Bayer's Wenning Tries to Fix Drug Unit With Schering (Update2) Mar 24, 2006
The 59-year-old executive took charge of Leverkusen, Germany-based Bayer in 2002 after the withdrawal of anti- cholesterol drug Baycol. ... - Bloomberg
Bayer Plans to Cut 6,000 Jobs After Schering Purchase (Update2) Mar 24, 2006
The 59-year-old executive took charge of Leverkusen, Germany-based Bayer in 2002 after the withdrawal of anti- cholesterol drug Baycol, which was linked to a ... - Bloomberg
Merck Won't Pursue Schering Bid, Paving Way for Bayer (Update2) Mar 24, 2006
Wenning, 59, took charge of Bayer in 2002 after the withdrawal of anti-cholesterol drug Baycol, which was linked to a muscle-wasting disease that killed ... - Bloomberg
Experts: Crestor Buzz Won't Boost Sales Mar 14, 2006
...from the market because there are fears it may cause the potentially lethal muscle wasting syndrome that led to the 2001 withdrawal of Baycol, a statin made by ... - Washington Post
Bayer Sells EU2 Bln Convertible Bonds to Fund Schering Purchase Mar 29, 2006
...as Chief Executive Officer Werner Wenning tries to fix the company's drug unit, still suffering from the 2001 withdrawal of the Baycol cholesterol treatment. ... - Bloomberg
Schering embraces $19.6B bid by Bayer Mar 25, 2006
Since it recalled its anti-cholesterol treatment Baycol in 2001 because of safety issues, Bayer has tried to find a partner for the unit. ... - Miami Herald
Too little, too late? Mar 29, 2006
...strong in over-the-counter therapies, Bayer's healthcare business took a major hit in 2001 when its cholesterol-lowering drug Lipobay (or Baycol) was withdrawn ... - Nature.com (subscription)
Merck KGaA Makes EU14.9 Billion Offer for Schering AG (Update1) Mar 12, 2006
Bayer is trying to make a pharmaceuticals comeback after the 2001 withdrawal of its Baycol anti-cholesterol forced it to rethink its strategy for its drugs ... - Bloomberg
Bayer mulls counterbid for Schering: sources Mar 23, 2006
The pharma business at the drugs and chemicals group has been held back by a $1-billion recall of cholesterol drug Baycol and generic competition to antibiotic ... - MSN Money
Merck KGaA Makes EU14.9 Billion Offer for Schering AG (Update3) Mar 12, 2006
Bayer, which also makes plastic and crop treatments, is trying to come back from the 2001 withdrawal of its Baycol anti- cholesterol, which forced a rethink of ... - Bloomberg
Bayer to bid for Schering, trumps Merck offer Mar 23, 2006
The pharma business at Bayer has been held back by a $1 billion recall of cholesterol drug Baycol and generic competition to antibiotic Cipro. ... - Reuters
Avaricious In Germany Mar 23, 2006
It had to recall its cholesterol drug Baycol, in 2001, to fight off a bevy of lawsuits. Antibiotic Cipro fell to generic competition. ... - Forbes
Schering Shares May Rise on $17.7 Billion Offer by Merck KGaA Mar 12, 2006
Bayer, which also makes plastics and crop treatments, is trying to fix its drug unit after the 2001 withdrawal of the Baycol anti-cholesterol medicine forced ... - Bloomberg
Schering Gets Bid From Bayer Mar 23, 2006
Bayer has struggled in drugs since the recall of its anticholesterol treatment Baycol over safety concerns in 2001, and it tried fruitlessly a few years ago to ... - New York Times
Bayer considers counterbid for Schering Mar 24, 2006
The pharma business at the drugs and chemicals group has been held back by a $US1-billion ($A1.4 billion) recall of cholesterol drug Baycol and generic ... - The Age
Anti-cholesterol drug Crestor reverses plaque buildup: study Mar 13, 2006
Crestor was the first cholesterol-lowering drug in a class known as statins to be introduced since Baycol was withdrawn in 2001 due to muscle problems called ... - Channel News Asia
White knight scuppers Merck bid for Schering Mar 24, 2006
...has been struggling to make strategic sense of its research and development business since 2001, when it was forced into a costly recall of Baycol, the heart ... - Times Online
Merck pulls out of bidding for Schering Mar 24, 2006
...roots. Bayer has struggled in drugs since the recall in 2001 of Baycol, its anticholesterol treatment, over safety concerns. It ... - International Herald Tribune
A Pick-Me-Up for German Pharma Mar 24, 2006
In 2001 it was forced to pull from the market its cholesterol-lowering drug Baycol, which has been linked to more than 100 deaths. ... - BusinessWeek
Merck Withdraws After Bayer Tops Bid for Schering Mar 24, 2006
The deal gives Bayer — still smarting from a $1 billion recall of the anticholesterol drug Baycol in 2001 — access to Yasmin, the Schering oral birth ... - New York Times
Bayer offer is the right medicine for Schering Mar 25, 2006
Buying Schering would boost Bayer’s pharmaceuticals unit, hit by the recall of its anti-cholesterol drug Baycol in 2001, so that healthcare would become the ... - Business Online
Experts: Crestor Buzz Won‘t Boost Sales Mar 14, 2006
..."Why not go with Vytorin which has no safety overhang," Anderson said. "The atmosphere around the withdrawal of Baycol has impacted Crestor," said Dr. Howard ... - Olberlin
(PRN) - ViroPharma Comments on Vancocin ... [+] Mar 17, 2006
...[+]. (PRN) - In Baycol Class Action, Philadelphia Court Grants Preliminary Approval of Nationwide Settlement for Third-Party Payors ... [+. ... - Bolsamania.com
Bowel-cleansing products, kidney failure are linked Mar 15, 2006
...org. Public Citizen warned consumers about the dangers of Vioxx, ephedra, Baycol and Propulsid years before the drugs were pulled. - Biloxi Sun Herald
DATAMONITOR: New Advertising Code of Conduct Established in ... Mar 10, 2006
Problems with drugs such as Rezulin (troglitazone) and Baycol (cerivastatin) for example, have had little effect on the blockbuster potential of competitor ... - PharmaLive.com
Bayer offers 16.3 bln euros for Schering Mar 23, 2006
Officer Werner Wenning is trying to rebuild the company’s drug division after sales slumped following the recall of the cholesterol-lowering Baycol in August ... - Daily Journal (subscription)
Bayer rides forth as Schering's white knight Mar 24, 2006
...company, Lanxess, and re-building the healthcare business in the wake of the damaging withdrawal of cholesterol-lowering drug Baycol/Lipobay (cerivastatin) in ... - Pharma Times (subscription)
Bayer bids for Schering to renew drug unit Mar 24, 2006
...week. The Bayer CEO took charge of Leverkusen, Germany-based Bayer in 2002 after the withdrawal of anti-cholesterol drug Baycol. ... - Shanghai Daily
New advertising code of conduct established in Vioxx withdrawal ... Mar 9, 2006
Problems with drugs such as Sankyo and Parke-Davis' Rezulin (troglitazone) and Bayer's Baycol (cerivastatin) for example, have had little effect on the ... - Pharmaceutical Business Review
Public Citizen Petitions FDA to Ban Darvon Feb 28, 2006
For example, Public Citizen warned consumers about the dangers of Vioxx, ephedra, Bextra, Rezulin, Baycol, Propulsid and many other drugs years before the ... - Consumer Affairs
Tysabri, an MS Drug with Potentially Deadly Side-Effects, Gets FDA ... Feb 18, 2006
Lotronex – 9 months; Duract – 11 months; Posicor – 12 months; Redux – 17 months ; Raplon – 19 months; Raxar – 23 months; Baycol – 27 months ... - Newsinferno.com,
Bayer: cardiovascular concerns could run deep Feb 3, 2006
...costs of litigation could also mean bad news for the company's bottom line, which has been struggling to make up for the withdrawal of cholesterol drug Baycol. ... - Pharmaceutical Business Review
Bayer's Trasylol Clotting Drug Boosts Heart Risk, Study Says Jan 25, 2006
Medicine. Bayer split off some chemical units last year as it tried to recover from the 2001 recall of the cholesterol treatment Baycol. ... - Bloomberg
Bayer falls on negative Trasylol study results Jan 26, 2006
...increased the risk for investors from Bayer's pharmaceuticals business, which is recovering from a $1 billion recall of cholesterol drug Baycol over patient ... - Reuters
The FDA's Label Fix Jan 18, 2006
Take, for instance, the 1999 label change for Baycol, a cholesterol drug from Bayer (nyse: BAY - news - people ) that has since been withdrawn from the market. ... - Forbes
Statin drugs must carry health warning Jan 13, 2006
A US Food and Drug Administration study last year found Baycol triggered the potential muscle disease 10 times more often than Lipitor, Zocor and Pravachol ... - Toronto Star
Pfizer says Lipitor shown equally safe at highest dose Jan 18, 2006
Concerns about the possibility of such muscle side effects have mounted since German drugmaker Bayer AG in 2001 withdrew its Baycol statin after it was linked ... - ABC News
Health Canada Mandates New Warnings on Statins Regarding Risk of ... Jan 14, 2006
Over the past year, however, the FDA found that Baycol, a statin which was taken off the market in August of 2001, increased the risk of this potential muscle ... - Newsinferno.com
Review shows Lipitor is safe, Pfizer says Jan 17, 2006
...condition. Bayer AG withdrew its Baycol statin in 2001, after it was linked 100 patient deaths, but not all statins are alike. The ... - Crain's New York Business
Federal medicine oversight criticized Jan 11, 2006
...with a few thousand patients, said Ray, who served as an expert witness in trials for liability cases involving Vioxx and Bayer AG's Baycol cholesterol drug. ... - Arizona Daily Star
Studies: Statins Don't Cut Risk of Colon, Other Cancers Jan 9, 2006
The specific statins studied included atorvastatin (Lipitor, Caduet), cerivastatin (Baycol), fluvastatin (Lescol), lovastatin (Advicor, Altoprev, Mevacor ... - ACS News Center
FDA Needs More Independence, Authority To Protect Consumers, NEJM ... Jan 12, 2006
Ray, who has served as an expert witness in trials for liability cases for Merck's Vioxx and Bayer's Baycol cholesterol drug, suggests splitting the drug ... - Kaiser network.org